Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03029468 · ClinicalTrials.gov registry record · NA

Computerized Cognitive Behavioral Therapy Assisted Life Management for Pain in Sickle Cell Disease

A NA study of Chronic Pain and Sickle Cell Disease, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
74
Enrollment target
1
Study location

NCT03029468: Completed NA study of Chronic Pain and Sickle Cell Disease, sponsored by University of Pittsburgh.

NCT03029468 is a NA study of Chronic Pain and Sickle Cell Disease that has completed, run by University of Pittsburgh. The registered enrollment target is 74 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03029468, a NA study of Chronic Pain and Sickle Cell Disease, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
74 participants
Enrollment target
1
Study location

Study Summary

The primary aim of this study is to test the feasibility and acceptability of implementing a multimedia computerized cognitive behavioral therapy (cCBT) program for reducing SCD pain symptoms in a single-arm pilot pragmatic clinical trial. The investigators will recruit 40 SCD patients with chronic pain and/or on chronic opioid pain treatment and randomize them 3:1 to two groups (cCBT and e-Education respectively), randomizing unevenly in order to best gather feasibility data for the cCBT. Both groups will use a mobile app to track daily pain/mood. The cCBT group will receive sessions of the CALM-SCD program to complete via mobile device and will have weekly follow-up with a care coach. The Education group will receive online education modules to complete via mobile device and will also have weekly follow-up with a care coach. The primary outcomes of the trial include feasibility (recruitment, retention, provider and patient feedback) and acceptability (sessions completed) of the CALM-SCD program.

Primary Outcome

Number of cCBT sessions completed

Interventions

  • BEHAVIORAL cognitive behavioral therapy
  • BEHAVIORAL eEducation

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 74 participants
Start Date 2018-03-28
Est. Completion 2020-09-01
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT03029468 record still lists

NCT03029468 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 74 participants, a relatively small participant target, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (90% lower).

The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which cognitive behavioral therapy is the first listed.

NCT03029468 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03029468 about?

NCT03029468 is a clinical study titled "Computerized Cognitive Behavioral Therapy Assisted Life Management for Pain in Sickle Cell Disease". The primary aim of this study is to test the feasibility and acceptability of implementing a multimedia computerized cognitive behavioral therapy (cCBT) program for reducing SCD pain symptoms in a single-arm pilot pragmatic clinical trial. The investigators will recruit 40 SCD patients with chronic ...

What is the current status of trial NCT03029468?

This trial is currently completed. It is a NA study. The enrollment target is 74 participants. The study started on 2018-03-28. Estimated completion is 2020-09-01.

What conditions does trial NCT03029468 study?

This clinical trial studies the following conditions: Chronic Pain, Sickle Cell Disease.

What interventions are being tested in trial NCT03029468?

The interventions under investigation include: cognitive behavioral therapy (BEHAVIORAL), eEducation (BEHAVIORAL).

Who is sponsoring clinical trial NCT03029468?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03029468 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03029468's enrollment target sits among peer trials

74 163rd of 301 higher than 139 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03422731 · 74 participants · Early Phase 1

    Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy

  • NCT03804853 · 74 participants · NA

    Rehabilitation Following Reverse Total Shoulder Arthroplasty

  • NCT04065776 · 74 participants · NA

    Evaluation of Hippocampal-Avoidance Using Proton Therapy in Low-Grade Glioma

  • NCT04771156 · 74 participants · Phase 4

    Ketorolac in Palatoplasty

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03029468, the US trial registry maintained by the National Library of Medicine. NCT03029468 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.